MediWound Ltd. (MDWD) Stock

MediWound Ltd. (MDWD) is a Healthcare stock trading at $14.20 (as of 2026-06-18), with a market capitalization of $175.91M and a trailing P/E of -6.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Valuation — source: SEC EDGAR (first-party)
Price	$14.20
Market Cap	$175.91M
P/E Ratio	-6.5
EV / EBITDA	-6.9
Price / Book	4.03
Price / Sales	10.37
DCF Value (model)	$-21.01
DCF Upside vs Price	-248.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$16.96M
Net Margin	-140.8%
Return on Equity	-54.7%
Current Ratio	2.33
Revenue Growth (YoY)	-16.1%
EPS Growth (YoY)	-30.7%

Valuation vs Sector & Industry
Stock P/E	-6.5
Sector P/E (Healthcare)	21.0
Industry P/E (Pharmaceutical Products)	17.3
vs Sector	-131.1%
vs Industry	-137.8%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	INVESTOR AB ($14.05M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Ofer Gonen
Employees	111
Country	IL
IPO Date	2014-03-20

Related Companies (Business model: Branded Consumer (CPG, Staples, Beauty, Alcohol, Pet, Nicotine); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.